Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action agonists, stimulants |
Mechanism KLF6 agonists(Kruppel like factor 6 agonists), STAT3 stimulants(Signal transducer and activator of transcription 3 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spinal Cord Injuries | Preclinical | United States | 14 Nov 2017 |